(2482 words)
AUTHORS CONTRIBUTIONS
All authors reviewed the manuscript. GA provided supervision, interpreted the data, and drafted the manuscript. dBF conceived and designed the study, and interpreted the data. DN conceived and designed the study, and interpreted the data. NB provided clinical study supervision and interpreted the data. JLF provided supervision and reviewed the manuscript. SX provided the statistical analysis.
CONFLICTS OF INTEREST
GA and NB are ALYATEC employees. DN is cofounder and ALYATEC employee. dBF is medical expert, cofounder, and shareholder of ALYATEC. dBF reports grants from STALLERGENES GREER, grants from CHIESI, and personal fees from ALK ABELLO, MUNDIPHARMA,
NOVARTIS, and REGENERON and is a member of the Board at STALLERGENES GREER, NOVARTIS, ALK ABELLO, MUNDIPHARMA, MEDAPHARMA, BOEHRINGER, ASTRAZENECA, and CALOR. JLF: none